Covered recipient · General Payments record
HARVEY MILLER RICHERT
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2025
$2,200.05
- Reported across 83 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $460.63 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.47 | 7 |
| Bausch & Lomb Americas Inc. | $96.84 | 1 |
| Alcon Vision LLC | $58.28 | 3 |
| BIOTISSUE HOLDINGS INC. | $37.81 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $34.24 | 1 |
| Ocular Therapeutix, Inc. | $20.68 | 1 |
| Amgen Inc. | $19.98 | 1 |
| Astellas Pharma US Inc | $19.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.33 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851686 | CMS |
| ABBVIE INC. | $8.62 | 02/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851691 | CMS |
| ABBVIE INC. | $30.26 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851697 | CMS |
| ABBVIE INC. | $33.46 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851701 | CMS |
| ABBVIE INC. | $4.80 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851708 | CMS |
| ABBVIE INC. | $33.32 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851712 | CMS |
| ABBVIE INC. | $30.68 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203851719 | CMS |
| Alcon Vision LLC | $19.17 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207499675 | CMS |
| Alcon Vision LLC | $18.54 | 07/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207499679 | CMS |
| Alcon Vision LLC | $20.57 | 10/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207499729 | CMS |
| Amgen Inc. | $19.98 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228641817 | CMS |
| Astellas Pharma US Inc | $19.33 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238608774 | CMS |
| Bausch & Lomb Americas Inc. | $96.84 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254788991 | CMS |
| BIOTISSUE HOLDINGS INC. | $37.81 | 02/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240147784 | CMS |
| Ocular Therapeutix, Inc. | $20.68 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250228641 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $34.24 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251001782 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.